Rare Stock Picks In March 2026 - From 23 Discerning Analysts [Seeking Alpha]
EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG) [Yahoo! Finance]
FDA Priority Review Puts Ionis Zilganersen At Center Of Rare-Disease Story [Yahoo! Finance]
Why Is Ionis Pharmaceuticals (IONS) Down 7.9% Since Last Earnings Report? [Yahoo! Finance]
Ionis Pharmaceuticals (IONS) had its price target raised by Barclays PLC from $95.00 to $106.00. They now have an "overweight" rating on the stock.